ArticleChina CDC weekly2026
Signal-Oriented Framework for Early Identification of Imported Respiratory Infectious Disease Risk.
Article in China CDC weekly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Increasing international travel and population mobility have made surveillance of imported infectious diseases more complex. However, current approaches still rely largely on confirmed epidemiological evidence and retrospective analyses of importation events. Their limited capacity to integrate heterogeneous information constrains early identification of emerging importation risks. Drawing on signal analysis theory, we developed a conceptual and operational framework for early identification of imported respiratory infectious disease risks involving human-to-human transmission. The framework conceptualizes imported disease risk as a dynamic process in which underlying risk factors generate observable surveillance indicators and event-based information that are progressively transformed into candidate risk signals, risk signals, and warning signals. We established an operational workflow comprising signal collection, integration, assessment, and escalation to organize heterogeneous evidence across the importation pathway. The framework incorporates four complementary domains: pathogen characteristics, overseas epidemic situation, cross-border importation risk, and post-entry transmission risk. These domains provide structured inputs for signal identification and assessment. Risk signals are evaluated according to signal characteristics, epidemiological stage, and consequence severity; they may be escalated to warning signals when predefined evidence and priority criteria are met. This framework provides an operational approach for integrating weak and heterogeneous information before importation events are fully confirmed, supporting earlier risk recognition and public health decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.